The progress within the life sciences sector in 2024 can be attributed to the advancements taking place with these 7 indicators suggestive of great potential.
The adoption of technology has already witnessed a growing momentum lately and in 2024 there will be a wider adoption of such tech for better outcomes.
Market expectations, economic pressures as well as regulations across the world are all going to add to the challenges of the pharmaceutical sector in 2024.
2024 may see some biopharma companies making an approach re-look in R&D, cutting down on projects and also resource allocation as part of regulations changes.
The paperwork reviews and plant visits are an occasional aspects of FDA functioning but drug safety according to them happens to be manufacturers ownership.
